CELL & GENE THERAPY INSIGHTS

Jan 2018. Vol 4 Suppl. 1

Jan 2018

FEATURING

Issue Spotlight: Anc-80: latest updates on the novel Anc-AAV gene therapy vector
Webinar

Spotlight

Anc-80: latest updates on the novel Anc-AAV gene therapy vector
Aug 2018

Research Article

Establishment of a scalable manufacturing platform for in-silico-derived ancestral adeno-associated virus vectors

Establishment of a scalable manufacturing platform for in-silico-derived ancestral adeno-associated virus vectors
Bingnan Gu,
Vijetha Bhat,
Wenling Dong,
Hai Pham,
Stephanie Pubill,
Nagarjun Kasaraneni,
Eric Onishi,
Francesca Vitelli,
Anandita Seth
12 November 2018
Research Article
Read more

Expert Insight

Addressing challenges in meeting chemistry, manufacturing and control regulatory requirements for gene therapy products

Addressing challenges in meeting chemistry, manufacturing and control regulatory requirements for gene therapy products
Karen Magers
24 July 2019
Expert Insight
Read more

Interview

Meeting the Demand: Next-Generation Viral Vectors for Gene Therapy

Meeting the Demand: Next-Generation Viral Vectors for Gene Therapy
Ryan Scanlon
19 November 2018
Interview
Read more
Flexible, Modular Manufacturing to Address Viral Vector Capacity Bottlenecks

Flexible, Modular Manufacturing to Address Viral Vector Capacity Bottlenecks
Xin Swanson
12 November 2018
Interview
Read more
Addressing the Limitations of AAV Vectors through Evolutionary Guided Vector Design

Addressing the Limitations of AAV Vectors through Evolutionary Guided Vector Design
Luk Vandenberghe
18 October 2018
Interview
Read more

Webinars

Development & manufacture of next-generation viral vectors for gene therapy

Development & manufacture of next-generation viral vectors for gene therapy
Anandita Seth
Anandita Seth, Head of Research & Development at Lonza Pharma & Biotech
20 June 2018
Webinar
Watch now